Results

Total Results: 428 records

Showing results for "schedule".

221. Disposition of Comments for Technical Brief 20 Core Functionality in Pediatric Electronic Health Records (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pediatric-ehr_disposition-comments.pdf
     May 01, 2015 - Immunization forecasting involves both routine preferred schedules and computation of catch up immunizations … viewpoint, it would simplify things substantially for pediatricians to have electronic vaccination schedules … the vaccination logic so that we can have an easily updatable, national standard for vaccination schedules … Many of today’s EHR are built following a paper model of fixed schedules of multiple doses in fixed

222. Data Points 13: Use of Preoperative Breast MRI among older women with ductal carcinoma in situ and locally invasive breast cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-mri-utilization_research.pdf
     August 01, 2012 - Data Points 13: Use of Preoperative Breast MRI among older women with ductal carcinoma in situ and locally invasive breast cancer Use of Preoperative Breast MRI Data Points # 13 Use of preoperative MRI among older women with ductal carcinoma in situ and locally invasive breast cancer Rates of MRI use prior to surg…

223. Future Research Needs for Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers, Long-Term Effectiveness in All Ages, and Variability in Prevalence, Diagnosis, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
     May 01, 2012 - To accommodate stakeholder schedules, we provided multiple time slots for the calls, meaning that the

224. Behavioral Programs for Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_executive.pdf
     September 11, 2015 - topics are based on needs assessment, and delivery timing/duration/location is based on participant’s schedule

225. FRN 29: Future Research Needs on Procalcitonin-Guided Antibiotic Therapy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin-future_research.pdf
     August 01, 2014 - FRN 29: Future Research Needs on Procalcitonin-Guided Antibiotic Therapy Future Research Needs Paper Number 29 Future Research Needs on Procalcitonin- Guided Antibiotic Therapy Future Research Needs Paper Number 29 Future Research Needs on Procalcitonin-Guided Antibiotic Therapy Identification of Fu…

226. Template for Reports Developed (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-future_research.pdf
     October 26, 2012 - Template for Reports Developed Future Research Needs Paper Number 17 Future Research Needs for Prevention and Treatment of Clostridium difficile Infection Future Research Needs Paper Number 17 Future Research Needs for Prevention and Treatment of Clostridium difficile Infection Identification o…

227. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
     January 01, 2007 - investigations need to take into account factors such as varying adherence because of administration schedules

228. Adverse Effects of First-Line Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-depression-research-protocol.pdf
     February 07, 2018 - recommendation is to choose a medication based on adverse event profiles, patient preferences, dosing schedules

229. CER 229 Evidence Summary: Opioid Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-229-opioid-treatments-chronic-pain-evidence-summary.pdf
     April 01, 2020 - CER 229 Evidence Summary: Opioid Treatments for Chronic Pain Purpose of Review To assess the effectiveness and harms of opioid therapy for chronic noncancer pain, alternative opioid dosing strategies, and risk mitigation strategies Key Messages • Opioids are associated with small improvements versus placebo in …

230. Lysosomal-Storage-Diseases-Therapies Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
     November 15, 2012 - Source: www.effectivehealthcare.ahrq.gov Published Online: November 15, 2012 1 Evidence-based Practice Center Technical Brief Protocol Project Title: Enzyme Replacement Therapy for Lysosomal Storage Disorders Amendment Date(s) if applicable: August 28, 2012 (Amendments Details–see Section VII) I. …

231. S103 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s103.pdf
     October 01, 2007 - ORIGINAL ARTICLE Using Inverse Probability-Weighted Estimators in Comparative Effectiveness Analyses With Observational Databases Lesley H. Curtis, PhD,*† Bradley G. Hammill, MS,* Eric L. Eisenstein, DBA,*† Judith M. Kramer, MD, MS,* and Kevin J. Anstrom, PhD*‡ Abstract: Inverse probability-weighted estimation is a…

232. Registry of Patient Registries (RoPR) Policies and Procedures (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/registry-of-patient-registries_research-2012-2_1.pdf
     January 01, 2012 - Registry of Patient Registries (RoPR) Policies and Procedures Research from the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Network May 2012 Effective Health Care Program Research Reports Number 41 Registry of Patient Registries (RoPR) Policies and Procedures Richard E. Gliklich, M.D. …

233. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - date for a decision has been released and the device is not yet listed on an FDA advisory committee schedule … been announced for an FDA decision, and the device does not yet appear on an FDA advisory committee schedule

234. Understanding Health-Systems’ Use of and Need for Evidence To Inform Decisionmaking (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-systems-research.pdf
     October 01, 2017 - Understanding Health-Systems’ Use of and Need for Evidence To Inform Decisionmaking White Paper Understanding Health-Systems’ Use of and Need for Evidence To Inform Decisionmaking Research White Paper Understanding Health-Systems’ Use of and Need for Evidence To Inform Decisionmaking Prepared for: Agency …

235. Methods Research Report: Linking Evidence Reviews to Organizational Guideline Planning: A Pilot Test of an Interactive Web-Based Presentation and Discussion of Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/linking-evidence-reviews-methods_0.pdf
     October 01, 2018 - Methods Research Report: Linking Evidence Reviews to Organizational Guideline Planning: A Pilot Test of an Interactive Web-Based Presentation and Discussion of Evidence Methods Research Report Linking Evidence Reviews to Organizational Guideline Planning: A Pilot Test of an Interactive, We…

236. Total Worker Health® (TWH) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/worker-health_executive.pdf
     April 01, 2016 - Work schedules (e.g., shift work, work hours), for example, have been highlighted as an Archived:

237. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
     January 01, 2016 - However, one research expert pointed out that the administration schedule for the fluocinolone acetonide … with newly diagnosed CSDME and data from the DRCRnet randomized controlled trial, the Medicare fee schedule

238. Version 2_Risk of Reinfection From SARS-CoV-2 -- An Update of an Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-2-risk-of-reinfection-from-SARSCoV2_0.pdf
     December 31, 2022 - Version 2_Risk of Reinfection From SARS-CoV-2 -- An Update of an Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review Rapid Evidence Product Version 2.0 (January 2022) Risk of Reinfection From SARS-CoV-2 – An Update of an Antibody Response Following SARS-Co…

239. Disposition of Comments for Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis -- Update of a 2007 Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
     March 01, 2012 - The approved Prolia® dosing schedule is an every-6-month injection. … Similarly, in Table 1 on page 11, Amgen requests changing the description of the denosumab dosing schedule … The dosing schedule description was changed as requested.

240. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - endoscopic evaluation or periodic Cytosponge monitoring as part of an appropriate surveillance schedule